PAPER Sala G, Arosio A, Stefanoni G, Melchionda L, Riva C, Marinig D, Brighina L, Ferrarese C
SEARCH RESULTS
331209 RESULTS
PAPER Chaudhuri A
Multiple sclerosis is primarily a neurodegenerative disease.
J Neural Transm. 2013 Oct;120(10):1463-6. PubMed: 23982272PAPER Milani P, Ambrosi G, Gammoh O, Blandini F, Cereda C
SOD1 and DJ-1 Converge at Nrf2 Pathway: A Clue for Antioxidant Therapeutic Potential in Neurodegeneration.
Oxid Med Cell Longev. 2013;2013:836760. PubMed: 23983902PAPER Yuan YS, Zhou XJ, Tong Q, Zhang L, Qi ZQ, Ge S, Zhang KZ
Change in Plasma Levels of Amino Acid Neurotransmitters and its Correlation with Clinical Heterogeneity in Early Parkinson's Disease Patients.
CNS Neurosci Ther. 2013 Nov;19(11):889-896. PubMed: 23981689PAPER Zhang Q, Vo N, Goodman RH
Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB.
Mol Cell Biol. 2000 Jul;20(14):4970-8. PubMed: 10866654PAPER Oueslati A, Schneider BL, Aebischer P, Lashuel HA
Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo.
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):E3945-54. PubMed: 23983262PAPER Peferoen L, Kipp M, van der Valk P, van Noort JM, Amor S
Review series on immune responses in neurodegenerative diseases: Oligodendrocyte-microglia cross-talk in the CNS.
Immunology. 2013 Aug 24; PubMed: 23981039PAPER Ito K, Sano T, Kamiya K, Nakata Y, Shigemoto Y, Sato N, Oya Y, Matsuda H
Massive accumulation of 11C-Pittsburg compound B in the occipital lobes of a patient with early-onset dementia accompanied by muscle weakness and hypertonicity.
Ann Nucl Med. 2013 Aug 27; PubMed: 23982949PAPER Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R, Larsen JP
Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2013 May;84(5):537-43. PubMed: 23117496PAPER Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D
Changes in motor subtype and risk for incident dementia in Parkinson's disease.
Mov Disord. 2006 Aug;21(8):1123-30. PubMed: 16637023PAPER Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
J Neurol Neurosurg Psychiatry. 2006 May;77(5):585-9. PubMed: 16614017PAPER Saito T
[Amyloidogenicity and pathogenicity of Abeta43 in Alzheimer's disease].
Seikagaku. 2013 Jul;85(7):543-52. PubMed: 23980468PAPER Algarabel S, Fuentes M, Escudero J
On familiarity deficits in mild cognitive impairment: A reply to Migo and Westerberg.
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2013 Aug 28; PubMed: 23980648PAPER Hou LN, Xu JR, Zhao QN, Gao XL, Cui YY, Xu J, Wang H, Chen HZ
A New Motif in the N-Terminal of Acetylcholinesterase Triggers Amyloid-β Aggregation and Deposition.
CNS Neurosci Ther. 2013 Aug 24; PubMed: 23981668PAPER Teplow DB
On the subject of rigor in the study of amyloid β-protein assembly.
Alzheimers Res Ther. 2013 Aug 27;5(4):39. PubMed: 23981712Current Filters
No filters selected